Ionis Pharmaceuticals (IONS) Prepaid Assets (2009 - 2026)
Ionis Pharmaceuticals' (IONS) quarterly Prepaid Assets came in at $306.1 million in Q1 2026, up 37.52% year-on-year from $222.6 million in Q1 2025, and up 29.1% quarter-over-quarter from $237.1 million in Q4 2025.
Ionis Pharmaceuticals (IONS) Prepaid Assets (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Prepaid Assets history runs 18 years deep, the most recent figure standing at $306.1 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 37.52% year-over-year to $306.1 million in Q1 2026; TTM through Mar 2026 was $306.1 million, a 37.52% increase from a year earlier, with the FY2025 full-year figure at $237.1 million, up 8.79% from the prior year.
- Prepaid Assets improved to $306.1 million in Q1 2026 per IONS's latest filing, from $237.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $306.1 million in Q1 2026 and bottomed at $142.8 million in Q2 2022.
- The 5-year median for Prepaid Assets is $184.2 million (2024), against an average of $196.2 million.
- Across the five-year window, Prepaid Assets rose 1.72% in 2024 and jumped 37.52% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $168.3 million in 2022, then gained by 22.1% to $205.4 million in 2023, then climbed by 6.09% to $217.9 million in 2024, then gained by 8.79% to $237.1 million in 2025, then rose by 29.1% to $306.1 million in 2026.
- Per Business Quant, the three latest IONS Prepaid Assets figures stand at $306.1 million (Q1 2026), $237.1 million (Q4 2025), and $243.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ionis Pharmaceuticals | 9.21 Bn | 7.29 Bn | 243.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 306.08 Mn |
| Dec 31, 2025 | 237.09 Mn |
| Sep 30, 2025 | 243.74 Mn |
| Jun 30, 2025 | 226.11 Mn |
| Mar 31, 2025 | 222.57 Mn |
| Dec 31, 2024 | 217.93 Mn |
| Sep 30, 2024 | 184.19 Mn |
| Jun 30, 2024 | 194.72 Mn |
| Mar 31, 2024 | 174.06 Mn |
| Dec 31, 2023 | 205.43 Mn |
| Sep 30, 2023 | 181.08 Mn |
| Jun 30, 2023 | 177.87 Mn |
| Mar 31, 2023 | 159.72 Mn |
| Dec 31, 2022 | 168.25 Mn |
| Sep 30, 2022 | 143.17 Mn |
| Jun 30, 2022 | 142.76 Mn |
| Mar 31, 2022 | 150.58 Mn |
| Dec 31, 2021 | 143.37 Mn |
| Sep 30, 2021 | 136.64 Mn |
| Jun 30, 2021 | 131.05 Mn |